-
公开(公告)号:US20130280286A1
公开(公告)日:2013-10-24
申请号:US13483701
申请日:2012-05-30
申请人: Christoph VON EICHEL-STREIBER , Jessica REINEKE , Stefan TENZER , Hansjörg SCHILD , Maja RUPNIK
发明人: Christoph VON EICHEL-STREIBER , Jessica REINEKE , Stefan TENZER , Hansjörg SCHILD , Maja RUPNIK
IPC分类号: A61K31/6615 , C12N9/99 , C07K14/33 , A61K31/336 , C07K16/40
CPC分类号: C07K14/33 , A61K31/04 , A61K31/336 , A61K31/661 , A61K31/6615 , A61K39/08 , A61K2039/505 , C07K16/1282 , C07K16/40 , C07K2317/76 , C12N9/99
摘要: The medicament for the prevention or the relief of poisoning by large clostridial cytotoxins (LCTs), in particular Clostridium difficile toxins A and B (TcdA and TcdB), is characterized by containing as active ingredient at least one effector, namely an inhibitor or activator of the autocatalytic protease activity of LCTs (large clostridial cytotoxins).
-
公开(公告)号:US20090311258A1
公开(公告)日:2009-12-17
申请号:US12376036
申请日:2007-05-26
申请人: Christoph Von Eichelstreiber , Jessica Reineke , Stefan Tenzer , Hansjoerg Schild , Maja Rupnik
发明人: Christoph Von Eichelstreiber , Jessica Reineke , Stefan Tenzer , Hansjoerg Schild , Maja Rupnik
IPC分类号: A61K39/395 , A61K31/335 , A61K31/70 , A61K39/00
CPC分类号: C07K14/33 , A61K31/04 , A61K31/336 , A61K31/661 , A61K31/6615 , A61K31/7024 , A61K39/08 , A61K2039/505 , C07K16/1282 , C07K16/40 , C07K2317/76 , C12N9/99
摘要: The medicament for the prevention or the relief of poisoning by large clostridial cytotoxins (LCTs), in particular Clostridium difficile toxins A and B (TcdA and TcdB), is characterized by containing as active ingredient at least one effector, namely an inhibitor or activator of the autocatalytic protease activity of LCTs (large clostridial cytotoxins).
摘要翻译: 用于预防或缓解大梭菌细胞毒素(LCT),特别是艰难梭菌毒素A和B(TcdA和TcdB)的中毒的药物的特征在于,含有作为活性成分的至少一种效应物,即抑制剂或活化剂 LCTs(大梭菌细胞毒素)的自催化蛋白酶活性。
-
公开(公告)号:US09066961B2
公开(公告)日:2015-06-30
申请号:US13483701
申请日:2012-05-30
申请人: Christoph Von Eichelstreiber , Jessica Reineke , Stefan Tenzer , Hansjoerg Schild , Maja Rupnik
发明人: Christoph Von Eichelstreiber , Jessica Reineke , Stefan Tenzer , Hansjoerg Schild , Maja Rupnik
IPC分类号: A61K31/56 , A61K31/6615 , A61K31/04 , A61K31/661 , A61K39/08 , C07K16/12 , A61K31/336 , C07K14/33 , C07K16/40 , C12N9/99 , A61K39/00
CPC分类号: C07K14/33 , A61K31/04 , A61K31/336 , A61K31/661 , A61K31/6615 , A61K39/08 , A61K2039/505 , C07K16/1282 , C07K16/40 , C07K2317/76 , C12N9/99
摘要: The medicament for the prevention or the relief of poisoning by large clostridial cytotoxins (LCTs), in particular Clostridium difficile toxins A and B (TcdA and TcdB), is characterized by containing as active ingredient at least one effector, namely an inhibitor or activator of the autocatalytic protease activity of LCTs (large clostridial cytotoxins).
摘要翻译: 用于预防或缓解大梭菌细胞毒素(LCT),特别是艰难梭菌毒素A和B(TcdA和TcdB)的中毒的药物的特征在于,含有作为活性成分的至少一种效应物,即抑制剂或活化剂 LCTs(大梭菌细胞毒素)的自催化蛋白酶活性。
-
-